INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q4 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $18 | -99.3% | 1 | -99.2% | 0.00% | – |
Q4 2022 | $2,597 | -35.1% | 130 | -24.0% | 0.00% | -100.0% |
Q3 2022 | $4,000 | +33.3% | 171 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -57.1% | 171 | -44.1% | 0.00% | -100.0% |
Q1 2022 | $7,000 | +40.0% | 306 | +60.2% | 0.00% | 0.0% |
Q4 2021 | $5,000 | -16.7% | 191 | -14.7% | 0.00% | 0.0% |
Q3 2021 | $6,000 | +100.0% | 224 | +148.9% | 0.00% | 0.0% |
Q2 2021 | $3,000 | -25.0% | 90 | -17.4% | 0.00% | -50.0% |
Q1 2021 | $4,000 | – | 109 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |